product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
FNBP1 Antibody - BSA Free
catalog :
NBP1-47260
quantity :
100 ul
price :
459 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
more info or order :
citations: 3
Reference |
---|
product information
master code :
NBP1-47260
SKU :
NBP1-47260
product name :
FNBP1 Antibody - BSA Free
unit size :
100 ul
description :
The FNBP1 Antibody - BSA Free from Novus is a rabbit polyclonal antibody to FNBP1. This antibody reacts with human. The FNBP1 Antibody - BSA Free has been validated for the following applications: Western Blot,Microarray,Immunoprecipitation.
target :
FNBP1
category :
Primary Antibodies
buffer :
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
clonality :
Polyclonal
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Rabbit
immunogen :
The immunogen for this product maps to a region between residue 350 and 400 of human Formin-Binding Protein 17 using the numbering given in entry NP_055848.1 (GeneID 23048).
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human
gene symbol :
FNBP1
Antibody validation :
Independent Anitbodies
applications :
Western Blot,Microarray,Immunoprecipitation
USD :
459 USD
alt names :
FBP17KIAA0554Formin-binding protein 17, formin binding protein 1, formin-binding protein 1, hFBP17, MGC126804
storage :
Store at 4C. Do not freeze.
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
related products
browse more products
questions and comments